$PLX - One of my faves, Creating Positive Momentum

AMEX:PLX   Protalix BioTherapeutics, Inc. (DE)
PLX Could Claim Substantial Global Market Share In Fabry Disease.
April 27, BLA approval opportunity.

Technically, resistances in rage, 4.87 and 5.2.
Support level 4.4-4.35.

Not recommended to buy or sell PLX stocks (Very risky).
Just an Idea.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.